Financhill
Buy
58

CL Quote, Financials, Valuation and Earnings

Last price:
$95.09
Seasonality move :
4.45%
Day range:
$93.39 - $95.11
52-week range:
$74.55 - $100.18
Dividend yield:
2.19%
P/E ratio:
36.27x
P/S ratio:
3.78x
P/B ratio:
89.54x
Volume:
6.6M
Avg. volume:
7.5M
1-year change:
8.22%
Market cap:
$76.6B
Revenue:
$20.4B
EPS (TTM):
$2.62

Analysts' Opinion

  • Consensus Rating
    Colgate-Palmolive Co. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 6 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $96.42, Colgate-Palmolive Co. has an estimated upside of 1.4% from its current price of $95.09.
  • Price Target Downside
    According to analysts, the lowest downside price target is $87.00 representing 8.51% downside risk from its current price of $95.09.

Fair Value

  • According to the consensus of 12 analysts, Colgate-Palmolive Co. has 1.4% upside to fair value with a price target of $96.42 per share.

CL vs. S&P 500

  • Over the past 5 trading days, Colgate-Palmolive Co. has underperformed the S&P 500 by -2.17% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Colgate-Palmolive Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Colgate-Palmolive Co. has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Colgate-Palmolive Co. reported revenues of $5.2B.

Earnings Growth

  • Colgate-Palmolive Co. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Colgate-Palmolive Co. reported earnings per share of -$0.05.
Enterprise value:
83.7B
EV / Invested capital:
--
Price / LTM sales:
3.78x
EV / EBIT:
19.10x
EV / Revenue:
4.10x
PEG ratio (5yr expected):
9.41x
EV / Free cash flow:
23.02x
Price / Operating cash flow:
21.22x
Enterprise value / EBITDA:
16.70x
Gross Profit (TTM):
$12.3B
Return On Assets:
13.45%
Net Income Margin (TTM):
11.09%
Return On Equity:
287.39%
Return On Invested Capital:
24.63%
Operating Margin:
20.59%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $19.5B $20.1B $20.4B $4.9B $5.2B
Gross Profit $11.3B $12.2B $12.3B $3B $3.1B
Operating Income $4.2B $4.5B $4.4B $1.1B $1.1B
EBITDA $4.8B $5.1B $5B $1.2B $1.3B
Diluted EPS $2.78 $3.51 $2.62 $0.90 -$0.05
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $4.4B $5.1B $5.3B $5.3B $5.7B
Total Assets $15B $15.7B $16.4B $16B $16.3B
Current Liabilities $4.1B $4B $4.7B $5.8B $5.7B
Total Liabilities $14.1B $14.9B $15.4B $15.5B $16B
Total Equity $971M $806M $957M $544M $365M
Total Debt $7.7B $9.2B $8.7B $8.4B $8B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations $3.7B $4.1B $4.2B $1.3B $1.5B
Cash From Investing -$742M -$534M -$817M -$80M -$103M
Cash From Financing -$2.8B -$3.4B -$3.3B -$1.3B -$1.4B
Free Cash Flow $3B $3.5B $3.6B $1.1B $1.3B
CL
Sector
Market Cap
$76.6B
$106.9M
Price % of 52-Week High
94.92%
75.17%
Dividend Yield
2.19%
0%
Shareholder Yield
4.49%
2.16%
1-Year Price Total Return
8.22%
-1.91%
Beta (5-Year)
0.290
0.244
Dividend yield:
2.19%
Annualized payout:
$2.06
Payout ratio:
57.32%
Growth streak:
36 years

Technicals

8-day SMA
Sell
Level $95.30
200-day SMA
Buy
Level $84.50
Bollinger Bands (100)
Buy
Level 75.79 - 87.55
Chaikin Money Flow
Buy
Level 24.5M
20-day SMA
Buy
Level $92.17
Relative Strength Index (RSI14)
Buy
Level 67.75
ADX Line
Buy
Level 52.85
Williams %R
Neutral
Level -37.8109
50-day SMA
Buy
Level $85.01
MACD (12, 26)
Buy
Level 21.43
25-day Aroon Oscillator
Buy
Level 76
On Balance Volume
Neutral
Level 49M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (7.2613)
Sell
CA Score (Annual)
Level (-1.0175)
Buy
Beneish M-Score (Annual)
Level (-2.9289)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.9027)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

Stock Forecast FAQ

In the current month, CL has received 6 Buy ratings 6 Hold ratings, and 0 Sell ratings. The CL average analyst price target in the past 3 months is $96.42.

  • Where Will Colgate-Palmolive Co. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Colgate-Palmolive Co. share price will rise to $96.42 per share over the next 12 months.

  • What Do Analysts Say About Colgate-Palmolive Co.?

    Analysts are divided on their view about Colgate-Palmolive Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Colgate-Palmolive Co. is a Sell and believe this share price will drop from its current level to $87.00.

  • What Is Colgate-Palmolive Co.'s Price Target?

    The price target for Colgate-Palmolive Co. over the next 1-year time period is forecast to be $96.42 according to 12 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.

  • Is CL A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Colgate-Palmolive Co. is a Leans Bullish. 6 of 12 analysts rate the stock a Leans Bullish at this time.

  • How Can I Buy Shares Of CL?

    You can purchase shares of Colgate-Palmolive Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Colgate-Palmolive Co. shares.

  • What Is The Colgate-Palmolive Co. Share Price Today?

    Colgate-Palmolive Co. was last trading at $95.09 per share. This represents the most recent stock quote for Colgate-Palmolive Co.. Yesterday, Colgate-Palmolive Co. closed at $95.09 per share.

  • How To Buy Colgate-Palmolive Co. Stock Online?

    In order to purchase Colgate-Palmolive Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock